5,422
edits
(Created page with "'''Heart failure''' is a clinical syndrome where the patient has symptoms and/or signs of insufficient cardiac output and/or backwards congestion. This is due to an underlying decrease in systolic or diastolic function of the heart. Decreased systolic function refers to decreased ability of the heart to eject blood, reflected as a decreased left ventricular ejection fraction (<abbr>LVEF</abbr>, usually shortened to simply EF). Decreased diastolic function refers...") |
No edit summary |
||
Line 217: | Line 217: | ||
Notably, ACE inhibitors, ARBs, ARNIs, and beta blockers have shown to have very little to not benefit in HFpEF. MRAs ''may'' provide a small benefit. Ongoing trials will reveal whether other drugs are useful for HFpEF. | Notably, ACE inhibitors, ARBs, ARNIs, and beta blockers have shown to have very little to not benefit in HFpEF. MRAs ''may'' provide a small benefit. Ongoing trials will reveal whether other drugs are useful for HFpEF. | ||
[[Category:Cardiology]] | [[Category:Cardiology]] | ||
[[Category:Internal Medicine (POTE course)]] |